Simulation of a long narrow type constructed wetland using the stream model QUAL2K

被引：0
|
作者：
Jou, Chih-Ju [1 ]
Lee, Chien-Li [2 ]
Fu, Yue-Teng Vincent [3 ]
Kao, Chih-Ming [3 ]
机构：
[1] Department of Safety, Health and Environmental Engineering, National Kaohsiung First University of Science and Technology, Kaohsiung,811, Taiwan
[2] Research and Development Center for Water Resource and Conservation, National Kaohsiung First University of Science and Technology, Kaohsiung,811, Taiwan
[3] Institute of Environmental Engineering, National Sun Yat-sen University, Kaohsiung,804, Taiwan
来源：
Sustainable Environment Research | 2012年 / 22卷 / 04期
关键词：
Rivers - Water treatment - Biochemical oxygen demand - Water quality - Wetlands - Rate constants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：255 / 260
相关论文
共 50 条
  • [41] Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model
    Mehta, Ashish
    Ramachandra, Chrishan J. A.
    Singh, Pritpal
    Chitre, Anuja
    Lua, Chong Hui
    Mura, Manuela
    Crotti, Lia
    Wong, Philip
    Schwartz, Peter J.
    Gnecchi, Massimiliano
    Shim, Winston
    EUROPEAN HEART JOURNAL, 2018, 39 (16) : 1446 - +
  • [42] Simulation of micro- and macrovascular outcomes in a Type 2 diabetes population using the diabetes mellitus model:: effect of improved glycaemic control.
    Müller, E
    Walleser, S
    Maxion-Bergemann, S
    Bergemann, R
    DIABETOLOGIA, 2003, 46 : A438 - A438
  • [43] Proteomic analysis of serum biomarkers for prediabetes using the Long-Evans Agouti rat, a spontaneous animal model of type 2 diabetes mellitus
    Takahashi, Eri
    Unoki-Kubota, Hiroyuki
    Shimizu, Yukiko
    Okamura, Tadashi
    Iwata, Wakiko
    Kajio, Hiroshi
    Yamamoto-Honda, Ritsuko
    Shiga, Tomoko
    Yamashita, Shigeo
    Tobe, Kazuyuki
    Okumura, Akinori
    Matsumoto, Michihiro
    Yasuda, Kazuki
    Noda, Mitsuhiko
    Kaburagi, Yasushi
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (05): : 661 - 671
  • [44] USE OF A DISCRETE EVENT SIMULATION MODEL TO ESTIMATE LONG TERM ECONOMIC OUTCOMES OF BARIATRIC SURGERY IN MORBIDLY-OBESE, TYPE-2 DIABETIC PATIENTS IN MEXICO
    Zanela, O. O.
    Cabra, H. A.
    Anaya, P.
    Rodriguez, S.
    Melendez, G.
    Rupprecht, F.
    VALUE IN HEALTH, 2011, 14 (07) : A568 - A568
  • [45] Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)
    McEwan, P
    Peters, JR
    Bergenheim, K
    Currie, CJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (01) : 121 - 129
  • [46] Regional simulation of long-term organic carbon stock changes in cropland soils using the DNDC model: 2. Scenario analysis of management options
    Sleutel, S.
    De Neve, S.
    Beheydt, D.
    Li, C.
    Hofman, G.
    SOIL USE AND MANAGEMENT, 2006, 22 (04) : 352 - 361
  • [47] ASSESSING SIMULATION RUN TIME REQUIREMENTS TO ACHIEVE STABILIZED ABSOLUTE AND INCREMENTAL COST EFFECTIVENESS RESULTS IN TYPE 2 DIABETES: A STUDY USING THE IMS CORE DIABETES MODEL
    Foos, V
    Grant, D.
    McEwan, P.
    VALUE IN HEALTH, 2014, 17 (03) : A252 - A252
  • [48] Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes -: a simulation with the Diabetes Mellitus Model (DMM)
    Janka, H. U.
    Hessel, F.
    Walzer, S.
    Mueller, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (12) : 623 - 630
  • [49] LONG-TERM CLINICAL OUTCOMES OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR THE TREATMENT OF TYPE 2 DIABETES PROJECTED USING THE CORE DIABETES MODEL
    Timlin, L.
    Beaudet, A.
    Wilson, B.
    Bruhn, D.
    Boye, K. S.
    Palmer, J. L.
    Lloyd, A.
    VALUE IN HEALTH, 2010, 13 (07) : A284 - A285
  • [50] QUANTIFYING NONLINEAR EFFECTS IN STOCHASTIC MARKOV SIMULATION USING UKPDS 68 AND UKPDS 82 EQUATIONS IN TYPE 2 DIABETES MODELING ANALYSIS WITH THE IMS CORE DIABETES MODEL (CDM)
    McEwan, P.
    Grant, D.
    Lamotte, M.
    Foos, V
    VALUE IN HEALTH, 2014, 17 (07) : A546 - A546
12345